McBride (10W) AI Stock Analysis
McBride
(Frankfurt:10W)
No summary available
McBride (10W) vs. iShares MSCI Germany ETF (EWG)
- Market Cap
- EUR 291.35M
- Dividend Yield
- 1.87%
- Average Volume (3M)
- 1,736
- Price to Earnings (P/E)
- 10.1
- Beta (1Y)
- 0.76
- Revenue Growth
- -2.49%
- EPS Growth
- -12.26%
- Country
- Germany
- Employees
- 3,236
- Sector
- Consumer Defensive
- Sector Strength
- 62
- Industry
- Household & Personal Products
McBride Business Overview & Revenue Model
Company Description
McBride plc, alongside its subsidiaries, is a key developer and supplier of private label household and personal care goods. The company caters to both retailers and other brand proprietors across a broad geographical reach, encompassing the United K...
McBride Earnings Call Summary
The call was predominantly positive, with management highlighting strategic execution, the completed Eurotab acquisition, the transformational Vestacy agreement, strong private label trends, transformation benefits, shareholder returns and growth in aerosols and Asia. These positives were tempered by lower constant-currency revenue and operating profit, significant fourth-quarter input-cost inflation, delayed launches, pressure in Liquids and Unit Dosing, higher expected exceptional costs and continued uncertainty surrounding the external cost environment.
Q4-2026 Updates
Positive Updates
Negative Updates
Company Guidance
Management expects most delayed new product launches to start up in “this next first half year of the new financial year”; Eurotab is expected to add circa EUR 65 million of top line in “this current financial year,” while the Vestacy agreement is expected to grow revenues by an estimated GBP 170 million by the second half of financial year 2028, add some 180 million units per year and require McBride to spend approximately GBP 17 million over the next 3 years, with contract manufacturing beyond the 25% strategic ambition. The group remains committed to the 10% target for EBITDA margins and is on track for the cumulative GBP 50 million of transformation benefits by the end of FY '28; CapEx is expected to remain at current levels, the P&L finance charge is expected to increase to GBP 13 million in 2027, exceptional costs are expected to increase to some GBP 12 million in 2027, and further price rises will be required, with the oil price in the $100 to $110 range.
McBride Peers Comparison
Overall Rating
GB:NICL82.3Outperform
GB:W7L77Outperform
GB:PZC65Neutral
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| 82Outperform | GBP 394.95M | 16.77 | 24.74% | 3.57% | 2.73% | 37.06% | |
| 77Outperform | GBP 152.83M | 11.88 | 15.76% | 7.24% | -8.34% | -22.09% | |
| 65Neutral | GBP 424.56M | 21.68 | 8.44% | 3.68% | 5.37% | ― | |
| Sector * | 62Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% |
* Consumer Defensive Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| DE:10W | McBride plc | 1.94 | 0.73 | 60.73% | |
| GB:NICL | Nichols plc | 1090.00 | 89.52 | 8.95% | |
| GB:PZC | PZ Cussons | 100.60 | 33.59 | 50.13% | |
| GB:W7L | Warpaint London | 183.00 | -19.50 | -9.63% |
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.